Zoe Johnson

Zoe Johnson

Company: iOnctura

Job title: Chief Scientific Officer

Seminars:

Afternoon Networking 5:00 pm

Live Demo in Virtual Exhibition Hall 1-1 Meetings Poster Session ROUND TABLE DISCUSSION: Isoforms Specific Agents vs Pan PI3K Inhibitors: Opportunities & ChallengesRead more

day: Day One

Live Q&A – Ask the Speakers Your Burning Questions 4:40 pm

Read more

day: Day One

Selective Targeting of PI3Kδ for the Treatment of Solid Tumours: Immune Mediated and Direct Anti-Cancer Activity 3:20 pm

iOnctura is developing a PI3Kδ small molecule inhibitor which has just entered a phase I clinical trial in solid tumours This presentation will discuss key preclinical data for the molecule and explore how this will inform the clinical development planRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.